OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
September 02, 2016
The strategies of a innovation-driven CMO may be different than a capacity-driven CMO.
September 01, 2016
Innovative technologies and services meet needs for existing and emerging biologic-based therapies.
The new facility is solely dedicated to offer extractables and leachables (E&L) testing services to the pharmaceutical and related industries.
The CordenPharma Chenôve, France manufacturing facility completed an FDA Inspection with no 483s reported.
API and drug product manufacturer changes name to align with parent company.
FDA found no observations during recent inspection of Regis Technologies manufacturing site.
Evonik’s parenteral drug delivery and commercial drug product manufacturing in Alabama passes EU GMP inspection.
The agreement comprises technology transfer and commercial manufacturing of Tillotts’ gastroenterology products.
August 25, 2016
Recipharm is investing EUR3.7 million (approximately $4.18 million) to increase lyophilization capacity at its Masate facility in Italy.
August 24, 2016
AMRI entered into a non-exclusive license agreement with the Broad Institute for the use of CRISPR-Cas9 gene-editing technology.